- Email: [email protected]
Cme Test Questions: July 2015
CME TEST QUESTIONS: JULY 2015
Examination available at http://learn.sirweb.org/. To take the online JVIR CME tests, please log into the SIR Learning Center with your SIR user name and password. Nonmembers: If you do not already have an SIR username and password, please click on “Create an Account” to gain access to the SIR Learning Center. Once in the Learning Center, click on the “Publication” activity type for a listing of all available JVIR CME Tests. Each test will be available online for 3 years from the month/date of publication. The CME questions in the July 2015 issue are derived from the article “Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis” by Han et al. 1. In this systematic review, the authors perform a meta-analysis of the clinical efficacy and safety of radiofrequency (RF) ablation for the treatment of intrahepatic cholangiocarcinoma (ICC). Based on their analysis, the pooled OVERALL 5-year survival was approximately a. 80% b. 50% c. 25% d. 10%
3. The authors describe technical effectiveness as complete ablation of the tumor demonstrated on contrastenhanced imaging obtained at least 1 month following RF ablation. Excluding the Carrafiello et al case series, which included tumors 4 5 cm, the technical effectiveness in per-lesion analysis ranged from a. o 50% b. 50%–70% c. 4 80% d. 4 95%
2. The pooled LOCAL progression rate, defined as a demonstration of nodular or irregular enhancement of the ablated tumor on a contrastenhanced, cross-sectional study obtained more than 1 month after the RF ablation, was approximately a. 90% b. 70% c. 50% d. 20%
4. While comparing the median survival time following RF ablation for ICC, the authors discuss a recent meta-analysis performed by Boehm et al for hepatic artery–based therapies for unresectable ICC. The pooled median survival following hepatic artery– based therapies, as reported by Boehm et al, was approximately a. 15 mo b. 20 mo c. 25 mo d. 30 mo
Examination available at http://learn.sirweb.org/. To take the online JVIR CME tests, please log into the SIR Learning Center with your SIR user name and password. Nonmembers: If you do not already have an SIR username and password, please click on “Create an Account” to gain access to the SIR Learning Center. Once in the Learning Center, click on the “Publication” activity type for a listing of all available JVIR CME Tests. Each test will be available online for 3 years from the month/date of publication. The CME questions in the July 2015 issue are derived from the article “Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis” by Han et al. 1. In this systematic review, the authors perform a meta-analysis of the clinical efficacy and safety of radiofrequency (RF) ablation for the treatment of intrahepatic cholangiocarcinoma (ICC). Based on their analysis, the pooled OVERALL 5-year survival was approximately a. 80% b. 50% c. 25% d. 10%
3. The authors describe technical effectiveness as complete ablation of the tumor demonstrated on contrastenhanced imaging obtained at least 1 month following RF ablation. Excluding the Carrafiello et al case series, which included tumors 4 5 cm, the technical effectiveness in per-lesion analysis ranged from a. o 50% b. 50%–70% c. 4 80% d. 4 95%
2. The pooled LOCAL progression rate, defined as a demonstration of nodular or irregular enhancement of the ablated tumor on a contrastenhanced, cross-sectional study obtained more than 1 month after the RF ablation, was approximately a. 90% b. 70% c. 50% d. 20%
4. While comparing the median survival time following RF ablation for ICC, the authors discuss a recent meta-analysis performed by Boehm et al for hepatic artery–based therapies for unresectable ICC. The pooled median survival following hepatic artery– based therapies, as reported by Boehm et al, was approximately a. 15 mo b. 20 mo c. 25 mo d. 30 mo